News

Lyophilization Services of New England (LSNE), a leading contract development and manufacturing organization, continues their expansion with the addition of increased cGMP storage…
Read More...

Samsung BioLogics (SBL) and UCB have agreed to an additional drug substance manufacturing deal under which SBL will also produce UCB's anti-tau candidate to treat progressive…
Read More...

The U.S. Food and Drug Administration (FDA) approved Nubeqa (darolutamide), an androgen receptor inhibitor (ARi), for the treatment of patients with non-metastatic castration-resistant…
Read More...

Pfizer Inc. announced the closing of its joint venture with GlaxoSmithKline plc to combine the parties’ respective consumer healthcare businesses to create the world’s largest…
Read More...

Endo International plc announced the appointment of Domenic Ciarico as Executive Vice President and Chief Commercial Officer, Sterile and Generics, effective immediately. In this…
Read More...

Marken announced the acquisition of PCX International Co. Ltd based in Japan. PCX operates from their Tokyo headquarters to coordinate the delivery of over 3,000 clinical trial…
Read More...

Pfenex Inc. and Arcellx, Inc. announced a Development, Evaluation and License agreement under which Arcellx gains access to the proprietary Pfenex Expression Technology platform to…
Read More...

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced that the University of Delaware, on behalf of NIIMBL, has entered into a Collaborative…
Read More...

Cambrex Corporation announced that it is expanding its solid form screening and crystallization process development facility in Edinburgh, Scotland, doubling the current footprint to…
Read More...

NeoGenomics, Inc. and Pharmaceutical Product Development, LLC (PPD) announced the grand opening of a NeoGenomics oncology-focused clinical trials testing lab in the same building as the…
Read More...

Novartis announced Kisqali (ribociclib) achieved statistically significant improvement in overall survival in the Phase III MONALEESA-3 clinical trial. This is the second Phase III…
Read More...

Alligator Bioscience announces that it has regained exclusive, worldwide rights from Janssen Biotech Inc. to develop and commercialize the CD40 agonistic antibody, ADC-1013…
Read More...

Exelixis, Inc. announced that it has entered into an exclusive collaboration, option and license agreement with Aurigene Discovery Technologies Limited (Aurigene), the India-based…
Read More...

Biopharmaceutical company Alvotech and Cipla Gulf FZ LLC ("Cipla Gulf"), a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited announced that Alvotech and…
Read More...

Nephron Pharmaceuticals Corporation and Rapid Micro Biosystems announced the Nephron 503(b) Outsourcing division will deliver critical medical supplies to hospitals faster than ever,…
Read More...

Eli Lilly and Company announced that Verzenio (abemaciclib) demonstrated a statistically significant improvement in overall survival in the Phase 3 MONARCH 2 clinical trial. These…
Read More...

Pfizer Inc. announced the successful completion of its acquisition of Array BioPharma Inc., advancing breakthrough science for the discovery, development and commercialization of…
Read More...

Lyndra Therapeutics, the company making daily pills a thing of the past, announced it has received a $13 million grant from the Bill & Melinda Gates Foundation for the development…
Read More...

Sunovion Pharmaceuticals Inc. (Sunovion) announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for dasotraline, a novel dopamine and…
Read More...

NEC Corporation announced the acquisition of OncoImmunity AS, a Norway-based bioinformatics company that develops proprietary machine learning software to support the fight against…
Read More...